Development of an ocular drug release system for cattle

dc.contributor.advisor Raymond T. Greer Dinh, Thomas
dc.contributor.department Chemical and Biological Engineering 2018-08-17T05:08:00.000 2020-07-02T06:14:44Z 2020-07-02T06:14:44Z Tue Jan 01 00:00:00 UTC 1991 1991
dc.description.abstract <p>An erodible ring-shaped ocular insert containing an antibiotic (tylosin tartrate) has been developed for treatment of infectious bovine keratoconjunctivitis (IBK). Four additional tasks have been completed: (1) a test to determine the retention time of the ocular device in the eyes of the calves, (2) an in vitro test to determine the degradation characteristics of the device, (3) an in vitro study to obtain the drug release profiles of the insert, and (4) a study to compare the use of rings and a field treatment method using infected cattle;The device remained in the eyes an average of 3.92 days, with the retention time ranging from 1 day to 6 days;The device completely dissolved in saline in 80 days. The device seemed to erode faster in the eyes of the calves than when used in in vitro tests;The drug release rate from the device after 5 days was still above the minimum release rate of 1.3 [mu]g/hr required to treat IBK infections;Two groups of Holstein calves were infected with Moraxella bovis, the agent that causes IBK. A comparison of the ocular ring treatment with that of a field method of treatment using subconjunctival injections of Azimycin°ler demonstrated that the treatment using the ring device was significantly more effective than the subconjunctival injection method. Clinical observations showed that the eyes receiving the medicated ocular devices improved while the eyes which were treated with subconjunctival injections of Azimycin°ler remained the same or worsened (p < 0.008). Also, bacterial evaluations performed by quantatively monitoring the number of bacteria in treated and control eyes for both treatment methods over a test period in excess of 5 days showed that the medicated ocular devices suppressed or kept the bacteria counts low (or nil) as compared to relatively high counts seen in those eyes that were treated with subconjunctival injections of Azimycin°ler (p < 0.03);The bioerodible ocular device has several advantages over conventional methods, including the subconjunctival injection method, in that it is more effective in treating IBK, is easy to insert, and can provide extended treatment therapy.</p>
dc.format.mimetype application/pdf
dc.identifier archive/
dc.identifier.articleid 10638
dc.identifier.contextkey 6360771
dc.identifier.s3bucket isulib-bepress-aws-west
dc.identifier.submissionpath rtd/9639
dc.language.iso en
dc.source.bitstream archive/|||Sat Jan 15 02:35:52 UTC 2022
dc.subject.disciplines Biomedical Engineering and Bioengineering
dc.subject.disciplines Medicinal and Pharmaceutical Chemistry
dc.subject.disciplines Medicinal Chemistry and Pharmaceutics
dc.subject.disciplines Medicinal-Pharmaceutical Chemistry
dc.subject.disciplines Polymer Chemistry
dc.subject.disciplines Veterinary Medicine
dc.subject.keywords Biomedical engineering
dc.title Development of an ocular drug release system for cattle
dc.type article
dc.type.genre dissertation
dspace.entity.type Publication
relation.isOrgUnitOfPublication 86545861-382c-4c15-8c52-eb8e9afe6b75 dissertation Doctor of Philosophy
Original bundle
Now showing 1 - 1 of 1
3.43 MB
Adobe Portable Document Format